FANGZHOU JIANKE (06086) deepens cooperation with Tencent Health and releases "AI + chronic disease management" solution to activate new industrial synergy ecology.

On November 27, FANGZHOU JIANKE (06086) held a "AI + Chronic Disease Management" solution launch event with Tencent Health, marking a new development stage in the domestic chronic disease management field. In this collaboration, both parties will provide full-chain support from technology verification to scenario implementation, and then to scale deployment for industry partners, injecting new energy into the intelligent, compliant, and efficient development of the industry. According to the introduction, the two parties complement each other based on their deep accumulation in their respective fields. FANGZHOU JIANKE, as a leading domestic "AI + Chronic Disease Management" service platform, has formed unique technological advantages and accumulated practical experience in the field of chronic disease management with its innovative "AI + H2H (Hospital to Home) Smart Healthcare New Ecology" (hereafter referred to as "AI + H2H ecosystem"). Tencent Cloud, as a leading cloud service provider in the industry, excels in key technology areas such as cloud computing, big data, and artificial intelligence. With the strong collaboration between the two parties, they will provide powerful technological support for the digital upgrade of "AI + Chronic Disease Management" in the industry. Efficiency soars, the value of "AI + Chronic Disease Management" shines This industry-facing solution is not a mere theory but is based on FANGZHOU JIANKE's effective practice in the field of "AI + Chronic Disease Management," and its value is concentratedly reflected through the platform's significant business data. In October this year, the number of users experiencing AI functions on the company's platform increased by 2.4 times compared to the previous month, showing strong growth momentum. In specific application scenarios, the precise response of AI technology to users' real pain points is particularly prominent. For example, the "Report Interpretation" function on the Jianke Doctor APP accurately addresses the common problem of patients not being able to understand their test reports. After the introduction of this function, the user inquiry rate and individual session numbers significantly increased, indicating that users have successfully built trust in the AI function. While AI significantly improves service efficiency, to ensure its reliable application in the highly sensitive field of healthcare, FANGZHOU JIANKE has deployed several security measures at the technological foundation level. To mitigate the risk of "hallucinations" that may arise with large models in professional medical scenarios, the technical team has optimized knowledge bases, supervised models, and upgraded compliance measures to minimize risks. These achievements stem from FANGZHOU JIANKE's ongoing promotion of the AI + H2H ecosystem strategy. This ecosystem, with its self-developed large model as the core intelligent engine, embeds AI technology deeply into business processes, forming a closed-loop service system covering the entire cycle of chronic disease management. In this system, the AI health steward provides services such as 24/7 health consultation, knowledge answers, report interpretation, and intelligent guidance; the AI medication assistant supports practical functions such as drug recognition through photos; the AI creation assistant empowers professional content production through functions such as video image AI analysis, AI script generation, and AI editing, efficiently breaking through the information barrier between doctors and patients. Based on the practical effectiveness of its AI + H2H ecosystem, FANGZHOU JIANKE further deepened its strategic cooperation with Tencent Health, aiming to transform validated AI capabilities into solutions that can empower the entire industry. Building industry solutions to drive AI capabilities into industries Based on the technology achievements and business value verified in the field of "AI + Chronic Disease Management," FANGZHOU JIANKE and Tencent Health further deepen their cooperation by jointly launching an industry-oriented "AI + Chronic Disease Management" solution, aiming to provide full-chain support from technology verification to scale deployment for industry partners. The solution integrates the AI capabilities accumulated by FANGZHOU JIANKE in vertical scenarios with Tencent Health's leading comprehensive service capabilities, helping industry partners achieve safe, efficient, and compliant digital upgrades. This solution is built on a solid technological foundation: FANGZHOU JIANKE, relying on Tencent Health's TI platform, has constructed a large model base, utilizing elastic computing power and one-stop training, testing, and deployment tools to efficiently fine-tune and continuously optimize models. Additionally, by introducing Tencent Health's vector database with a storage capacity of billions of professional knowledge combined with the RAG architecture, millisecond-level semantic retrieval can be achieved, significantly enhancing the accuracy and reliability of content generation. In the critical area of security and compliance, the company has adopted Tencent Health's intelligent body security WAF to build fine-grained security strategies tailored to medical scenarios, safeguarding the access routes of intelligent bodies and sensitive data, and assisting businesses in meeting compliance requirements. At the application level, the mature technology of FANGZHOU JIANKE and the underlying infrastructure of Tencent Health work closely together, ensuring the efficient development and agile iteration of intelligent bodies across multiple scenarios, helping to steadily improve service quality and operational efficiency. This launched solution deeply integrates the core strengths of both parties: FANGZHOU JIANKE contributes to a deep understanding of online medical service scenarios and professional model capabilities, while Tencent Health provides stable, secure, and efficient technical infrastructure. By jointly promoting this solution with both medical professionalism and industrial-level reliability, they empower the widespread application of AI technology in the medical field, aiding the industry in achieving high-quality digital transformation. This collaboration is not only a systematic output of technological capabilities but also an important exploration of the deep integration model of "artificial intelligence + healthcare." Recently, the National Health Commission and five other departments issued the "Implementation Opinions on Promoting and Regulating the Development of 'Artificial Intelligence + Medical Health' Applications," setting the stage for AI in healthcare to gradually become an important component of people's livelihood infrastructure. The collaboration between FANGZHOU JIANKE and Tencent Health is a response to policy calls and a vital practice in promoting the healthy development of the AI healthcare industry. Looking ahead, FANGZHOU JIANKE will continue to focus on technological innovation as the core driver and deepen cooperation with Tencent Health and more industry partners. Through technological innovation and ecosystem building, they aim to promote the development of chronic disease management services towards a more efficient, precise, and inclusive direction, contributing innovative power to the realization of the "Healthy China 2030" strategic goal and jointly embarking on a new chapter in smart healthcare with all sectors of the industry.